|
 |
| |
|
| |
|
| |
 |
| |
More Evidence that Size Matters
Big service providers get bigger faster thanks to Big Pharma.
|
| |
|
| |
| The Human Microbiome Project and Pharmaceutical Quality Control Microbiology
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
|
| |
|
| |
The Role of Regulatory Advice in Drug Development
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?
|
| |
 |
| |
| Alexion Acquires Synageva for $8.4 Billion
Alexion announces it will expand its rare disease pipeline with a definitive agreement to acquire Synageva.
|
| |
Want to learn more about tablet compression tooling and press setup? Natoli Engineering Company, a world-leading tablet compression solutions provider, offers an informative online knowledge base. We use the highest quality materials to manufacture efficient, durable and highly performing tablet compression tooling in all punch configurations including single-tip, multiple-tip, micro tab, exotic shapes, IMA Comprima, die table segments and more, from a variety of high-quality steel types and specialty coatings.
 Check out our online resources to see how we partner with our customers for success. |
| |
| Biosimilar Giants Launch Biosimilars Forum
Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars.
|
| |
| Biosimilars Will Bring Significant Litigation and Patent Challenges
Intellectual property lawyers estimate biosimilar litigation will swell as early as 2018.
|
| |
Practical Guidance for Successful Mammalian Cell Banking and Cell Line Characterization
Live Webinar: Thursday, May 14, 2015 at 8 am PDT/ 11 am EDT/ 4 pm BST/ 5 pm CEST
Join us for this informative webinar, presented by the team at Eurofins Lancaster Laboratories, to learn about the various aspects of cell banking and cell line characterization, including GMP production master and working cell banks, GMP non-production (e.g. bioassay) master and working cell banks, R&D cell banks or banking for end of production cells. Click here to register
|
| |
 |
| |
Teva Parenteral Medicines Recalls Adrucil
The company voluntarily recalls select lots of Adrucil due to particulate matter.
|
| |
Novo Nordisk Invests DKK1.5 Billion in New Manufacturing Facility
Novo Nordisk announces that it will invest DKK1.5 billion (US$224 million) in a haemophilia treatment manufacturing facility in Denmark.
|
| |
The Importance of Data Integrity in a GXP Regulated Laboratory
Live Webcast: Wednesday May 27, 2015 at 11:00 EDT; 15:00 GMT; 16:00 BST; 17:00 CET
With increased inspection scrutiny on data integrity, it is critical that managers and scientists in GXP regulated laboratories understand the current regulatory position. Discover the criteria for data integrity and learn how to assess and improve laboratory data management processes to ensure compliance with current regulations.
 Register for free
|
| |
Bayer Buys Rights to Isis Pharma's Blood Thinner for Up to $155 Million
Bayer announces that it will pay up to $155 million, plus royalties, for the rights to Isis Pharma's anti-clotting drug, ISIS-FXI.
|
| |
| The Acquisition Battle Continues with Another Perrigo Rejection
Ireland-based Perrigo rejects Mylan's second proposal for an acquisition valued at more than $34 billion, saying that the offer was too low to consider.
|
| |
Building the future Using Simulation Effectively
Live Webcast: Wednesday, June 3 at 8:00 am PDT / 10:00 am CDT / 11:00 am EDT
Join our free webinar for a case study on the handling of complex manufacturing expansion projects, with insight on simulation and visualization tools, innovations for manufacturing of parenterals, effective team building, and more. Register for free
|
| |
Takeda Faces Cancer Lawsuits with $2.4 Billion in Settlements
Takeda Pharmaceutical agrees to pay $2.4 billion to settle lawsuits from patients and family members who said the diabetes drug Actos caused bladder cancer.
|
| |
| Congress Encourages Modern Drug Manufacturing
The revised "21st Century Cures" proposal includes provisions for research for continuous manufacturing, biomarker development, and NIH funding.
|
| |
The largest, most influential biotech meeting in the world is coming to Philadelphia, June 15-18, 2015, offering powerful business partnering, invaluable education sessions and networking with the industry’s best and brightest. Join the global biotech community at BIO 2015 and fuel the extraordinary.
Register now at
 convention.bio.org.
|
| |
|
|
 |
Advertisement:
Pharmaceutical Technology Drug Delivery Guides
A three-volume set of drug delivery system handbooks. A compilation of articles related to methods and processes of manufacturing and administering pharmaceutical compounds to achieve therapeutic effects. Topics include the development of controlled-release formulations and reformulating injectable drugs for oral delivery.
... Click here |
Contact Us
Click here to contact editorial.
Click here to contact sales.
|
